Home › Essential Thrombocythemia › Utah
Essential Thrombocythemia clinical trials in Utah
4 studies for Essential Thrombocythemia are looking for participants at sites in Utah.
Cities in Utah
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
- Huntsman Cancer Institute/University of Utah, Salt Lake City
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT06661915A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
- Huntsman Cancer Institute At University of Utah, Salt Lake City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07623200A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
- Huntsman Cancer Institute At University of Utah, Salt Lake City
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 6, 2026 · NCT07008118Study of INCA036978 in Participants With Myeloproliferative Neoplasms
- Huntsman Cancer Institute, Salt Lake City
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 22, 2026 · NCT07441694From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.